Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024

Rhea-AI Summary

Novavax (NVAX) has scheduled its third quarter 2024 financial results and operational highlights conference call for November 12, 2024, at 8:30 a.m. ET. The company will host both a conference call and webcast, with replay options available until November 19, 2024, for the call and December 12, 2024, for the webcast. Participants can join through automated callback registration or direct operator assistance, and are advised to connect 10 minutes before the scheduled start.

GAITHERSBURG, Md., Nov. 4, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its third quarter 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Tuesday, November 12, 2024. Details of the event and replay are as follows:

Conference call details:
Date:	November 12, 2024
Time:	8:30 a.m. U.S. ET
URL to register phone:	https://emportal.ink/3Y6irHG
Dial-in number:	(800) 836-8184 (Domestic) or
	(+1) (646) 357-8785 (International)
Webcast:	ir.novavax.com/events

• Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
• Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
• To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.

Replay details:
Date:	Available starting at 11:30 a.m. ET, November 12, 2024, until 11:59 p.m. U.S. ET, November 19, 2024
Dial-in number:	(888) 660-6345 (Domestic) or
	(+1) (646) 517-4150 (International)
Passcode:	62491 #
Webcast:	ir.novavax.com/events, until December 12, 2024

 

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com

Media
Giovanna Chandler
202-709-5563
media@novavax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-third-quarter-2024-financial-results-and-operational-highlights-on-november-12-2024-302295599.html

SOURCE Novavax, Inc.

FAQ

When will Novavax (NVAX) report Q3 2024 earnings?

Novavax will report its Q3 2024 earnings on Tuesday, November 12, 2024, at 8:30 a.m. Eastern Time.

How can I access Novavax's (NVAX) Q3 2024 earnings call?

You can access the call by registering at the provided URL for automatic callback, dialing (800) 836-8184 (Domestic) or (+1) (646) 357-8785 (International), or visiting ir.novavax.com/events for the webcast.

How long will Novavax's (NVAX) Q3 2024 earnings call replay be available?

The call replay will be available from 11:30 a.m. ET on November 12 until November 19, 2024, while the webcast replay will be available until December 12, 2024.